The study looked at all 150 men who had a robotic
laparoscopic radical prostatectomy by Drs. Shalhav and Gregory Zagaja at the University of Chicago Hospitals between February 2003 and November 2004.
Patients with prostate cancer underwent robotic assisted
laparoscopic radical prostatectomy, while the benign disease group underwent transurethral resection of prostate.